Anavex Life Sciences Corp (AVXL)

[gburgin]

"So for once and for all: 2-73 either mono or combo is at the moment not protected by patents, pending a decision on the patent application."

For treatment of AD that is true.

2-73 IN COMBINATION with quinicrine, methylene blue, and atemazole is covered by the 2015 patent for treating cancer only.

There's also a patent application the company filed late last year that COULD be another combo patent using 2-73 but it is not published yet so nobody knows.